870601C

Azelaoyl-PAF

Avanti Research^™ - A Croda Brand 870601C

• 동의어(들): 1-hexadecyl-2-azelaoyl-sn-glycero-3-phosphocholine
• 실험식(Hill 표기법): C₃₃H₆₆NO₉P
• CAS Number: 354583-69-0
• Molecular Weight: 651.85
• MDL number: MFCD03412018
• UNSPSC 코드: 12352211
• NACRES: NA.25

속성

• 양식: liquid
• 포장: pkg of 1 × 1 mL (870601C-1mg)
• 제조업체/상표: Avanti Research^™ - A Croda Brand 870601C
• 농도: 1 mg/mL (870601C-1mg)
• 배송 상태: dry ice
• 저장 온도: −20°C
• SMILES string: [O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCCCCCC(O)=O)=O)COCCCCCCCCCCCCCCCC)=O
• InChI: 1S/C33H66NO9P/c1-5-6-7-8-9-10-11-12-13-14-15-16-20-23-27-40-29-31(30-42-44(38,39)41-28-26-34(2,3)4)43-33(37)25-22-19-17-18-21-24-32(35)36/h31H,5-30H2,1-4H3,(H-,35,36,38,39)/t31-/m1/s1
• InChI key: ZDFOCDTXDPKJKA-WJOKGBTCSA-N

설명

일반 설명

1-hexadecyl-2-azelaoyl-sn-glycero-3-phosphocholine (Azelaoyl-PAF) Azelaoyl-PAF is an alkyl phosphatidylcholine and is a component of the lipid pool within oxidized low-density lipoprotein (oxLDL) particles. Azelaoyl-PAF is a low molecular weight phospholipid.

애플리케이션

Azelaoyl-PAF may be used in binding assay of anti-inflammatory peptides, 2F and 4F.

생화학적/생리학적 작용

1-hexadecyl-2-azelaoyl-sn-glycero-3-phosphocholine (Azelaoyl-PAF) acts as an agonist for peroxisome proliferator-activated receptors γ(PPAR-γ). It may be used as a therapeutic for Friedreich′s ataxia (FRDA). At low concentrations azelaoyl-PAF may induce apoptosis.

포장

5 mL Clear Glass Sealed Ampule (870601C-1mg)

법적 정보

Avanti Research is a trademark of Avanti Polar Lipids, LLC

안전성 정보

• 픽토그램: GHS06,GHS08
• 신호어: Danger
• 유해 및 위험 성명서: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• 예방조치 성명서: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 표적 기관: Central nervous system, Liver,Kidney
• WGK: WGK 3